Validation of the New Interpretive Guidelines for the Clinical Dementia Rating Scale Sum of Boxes Score in the National Alzheimer's Coordinating Center Database
Overview
Authors
Affiliations
Background: It was recently demonstrated that the Clinical Dementia Rating scale Sum of Boxes (CDR-SB) score can be used to accurately stage severity of Alzheimer dementia and mild cognitive impairment (MCI). However, to our knowledge, the utility of those interpretive guidelines has not been cross-validated or applied to a heterogeneous sample of dementia cases.
Objective: To cross-validate the staging guidelines proposed in a previous study using the National Alzheimer's Coordinating Center (NACC) database.
Design: The previously published cut scores were applied to the NACC sample and diagnostic accuracy estimates obtained. Next, analyses were restricted to NACC participants with a CDR global score (CDR-GS) of 0.5 and receiver operating characteristic curves generated to determine optimal CDR-SB cut scores for distinguishing MCI from very early dementia.
Setting: The 2008 NACC uniform data set.
Participants: There were 12 462 participants (5115 controls; 2551 patients with MCI; 4796 patients with dementia, all etiologies) in the NACC data set used for the current analysis. Main Outcome Measure Accurate prediction of diagnoses (MCI or dementia) using the CDR-SB score.
Results: The previously proposed CDR-SB ranges successfully classified the vast majority of patients across all impairment ranges with a kappa of 0.91 and 94% overall correct classification rate. Additionally, the CDR-SB score discriminated between patients diagnosed with MCI and dementia when CDR-GS was restricted to 0.5 (overall area under the curve = 0.83).
Conclusions: These findings cross-validate the previously published CDR-SB interpretative guidelines for staging dementia severity and extend those findings to a large heterogeneous sample of patients with dementia. Additionally, the CDR-SB scores distinguished MCI from dementia in patients with reasonable accuracy when CDR-GS was restricted to 0.5.
Chronic stress, social support, and Alzheimer's blood-based biomarkers in the HABS-HD study.
Lee J, Johnson L, Hall J, Bateman J, Barnes L, OBryant S Alzheimers Dement. 2025; 21(3):e70043.
PMID: 40042512 PMC: 11881613. DOI: 10.1002/alz.70043.
Kim S, Kim J, Kim H, Kim L, Kim S Diagnostics (Basel). 2025; 15(4).
PMID: 40002598 PMC: 11854461. DOI: 10.3390/diagnostics15040448.
Spencer F, Elsworthy R, Breen L, Bishop J, Dunleavy C, Aldred S Trials. 2025; 26(1):20.
PMID: 39828710 PMC: 11744846. DOI: 10.1186/s13063-024-08696-4.
Elhage A, Cohen S, Cummings J, van der Flier W, Aisen P, Cho M Alzheimers Dement. 2024; 21(2):e14425.
PMID: 39697158 PMC: 11848336. DOI: 10.1002/alz.14425.
Gonzalez D, Finley J, Patel S, Soble J Am J Geriatr Psychiatry. 2024; 33(5):524-534.
PMID: 39551647 PMC: 11903187. DOI: 10.1016/j.jagp.2024.10.014.